IL1B and COVID-19: Most of the research focused attention on the first COVID-19 wave, in which high concentrations of IL-1β, tumor necrosis factor (TNF)-α, IL-6, IL-10, and interferon γ-induced protein (IP)-10 were observed in patients with severe forms of COVID-19.